Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8447024 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4115973 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2792012 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8864030 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8864069 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7758405 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8192721 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7758415 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7759354 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28488945 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0650732-B1 | NOVEL MEDICINAL COMPOSITION | KIRIN BREWERY (JP) | 2001-04-04 | — | — | EP | disclosed |
| US-6071884-A | ADMINISTERING TO THE PATIENT ATLEAST ONE ALPHA-GALACTOSYLCERAMIDE TO TREAT THROMBOCYTOPENIA | KIRIN BEER KABUSHIKI KAISHA (JP) | 2000-06-06 | — | — | US | disclosed |
| US-6017892-A | Method for accelerating marrow cell proliferation | KIRAN BEER KABUSHIKI KAISHA (JP) | 2000-01-25 | — | — | US | disclosed |
| US-5936076-A | ANTITUMOR/ANTICARCINOGENIC AGENTS; IMMUNOSTIMULATORS; THERAPY AGAINST INFECTIONS, AQUIRED IMMUNE DEFICIENCY SYNDROME | KIRIN BEER KABUSHIKI KAISHA (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0609437-B1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BREWERY (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5767092-A | Treatment of radiation-damaged bone marrow using galactosyl ceramides | KIRIN BEER KABUSHIKI KAISHA (JP) | 1998-06-16 | — | — | US | disclosed |
| US-5631356-A | Selective N-acylation of amino alcohols | GIST-BROCADES, N.V. (NL) | 1997-05-20 | — | — | US | disclosed |
| EP-0633875-B1 | SELECTIVE N-ACYLATION OF AMINO ALCOHOLS | GIST BROCADES NV (NL) | 1997-01-02 | — | — | EP | disclosed |
| EP-0650732-A1 | NOVEL MEDICINAL COMPOSITION | KIRIN BEER KABUSHIKI KAISHA (JP) | 1995-05-03 | — | — | EP | disclosed |
| EP-0609437-A1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BEER KABUSHIKI KAISHA (JP) | 1994-08-10 | — | — | EP | disclosed |